Spongipregnoloside B

Metabolite details

Identifier

JQFWUNNBRBJPRS-WYSHLAQCSA-N

InChI Key

JQFWUNNBRBJPRS-WYSHLAQCSA-N

IUPAC name

1-[(3S,8S,9S,10R,13S,14S,17S)-3-[(2R,4R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone

Preferred name

Spongipregnoloside B

INN name

—

Synonym

—

ChEBI

CHEBI:185763

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d